Changing Trends in Opioid Use Among Patients With Rheumatoid Arthritis in the United States
ConclusionIn the US, opioid use in older patients with RA peaked in 2010 and is now declining slightly. Withdrawal of propoxyphene from the US market in 2010 had minimal effect on overall opioid use, because use of propoxyphene was replaced by increased use of other opioids.
Source: Arthritis and Rheumatism - Category: Rheumatology Authors: Jeffrey R. Curtis, Fenglong Xie, Christian Smith, Kenneth G. Saag, Lang Chen, Timothy Beukelman, Melissa Mannion, Huifeng Yun, Stefan Kertesz Tags: Full Length Source Type: research
More News: Acetaminophen | Anxiety | Arthritis | Back Pain | Chronic Pain | Depression | Fibromyalgia | Hydrocodone | Lortab | Medicare | Pain | Propoxyphene | Rheumatoid Arthritis | Rheumatology | Study | Tramadol | Ultracet | USA Health | Vicodin